The American Society for Biochemistry and Molecular Biology (ASBMB) recently awarded full accreditation to the UMass Amherst biochemistry and molecular biology B.S. degree.

Aspects of the departments application that were considered particularly noteworthy according to the society include excellent faculty, outstanding in both teaching and research, integration of programs that promote student teamwork and communication skills, career advising and the advanced course-based undergraduate research experience (CURE) allowing students to gain authentic research experiences.

Jennifer Normanly, head of the department, says, Students who graduate from an ASBMB-accredited program have the opportunity to take an assessment, an exam, to have their degree certified by ASBMB, showing prospective graduate schools and potential employers that the students have met the societys high academic standards.

Dean Tricia Serio of the College of Natural Sciences said of the accomplishment, I am thrilled to see this well-deserved recognition for our stellar undergraduate major in biochemistry and for the departments leadership in and dedication to preparing our students for successful careers in the life sciences.

ASBMB, based in Rockville, Maryland, was founded in 1906 to advance the science of biochemistry and molecular biology through publication of scientific and educational journals, the organization of scientific meetings, advocacy for funding of basic research and education, support of science education at all levels and by promoting the diversity of individuals entering the scientific workforce. It publishes three peer-reviewed research journals covering research in microbiology, molecular genetics, RNA-related research, proteomics, genomics, transcription, peptides, cell signaling, lipidomics and systems biology. The society has over 12,000 members and has awarded accreditation to 85 colleges/universities.

Read more:
Biochemistry and Molecular Biology Degree Fully Accredited by ASBMB - UMass News and Media Relations

New York City, NY: Dec 12, 2019 Published via (Wired Release) The Biochemistry Analyzers Market Report characterizes and briefs perusers about its items, applications, and particulars. The examination records key organizations working in the market and furthermore features the key changing course received by the organizations to keep up their quality. By utilizing SWOT investigation and Porters five power examination instruments, the qualities, shortcomings, openings, and malediction of key organizations are out and out referenced in the report. Each and every driving player in this worldwide market is profiled with subtleties, for example, item types, business outline, deals, fabricating base, candidate, applications, and particulars.

Key players inside the Biochemistry Analyzers market are known through auxiliary investigation, and their pieces of the pie are resolved through essential and optional examination. All action shares split, and breakdowns are fearless exploitation auxiliary sources and checked essential sources. The Biochemistry Analyzers Market report starts with a fundamental rundown of the exchange lifecycle, definitions, characterizations, applications, and exchange chain structure and each one these along can encourage driving players to see the extent of the Market, what attributes it offers and the manner in which itll satisfy clients needs.

Want a free sample report?

Click Here, And Download Free Sample Copy OfBiochemistry Analyzers Market ResearchReport @https://marketresearch.biz/report/biochemistry-analyzers-market/request-sample

Our Free sample report provides a brief introduction to the research report overview, TOC, list of tables and figures, an overview of major market players and key regions included.

Major Players:

Abbott LaboratoriesDanaher CorporationHoffman-La Roche Ltd.MerilSiemens AGHologic Inc.Thermo Fisher Scientific, Inc.Randox Laboratories Ltd.Beckman Coulter Inc.Horiba Medical

Biochemistry Analyzers Market Research Methodology:

This investigation gauges it gives a point by point subjective and quantitative examination of the Biochemistry Analyzers market. Essential sources, for example, specialists from related enterprises and providers of Biochemistry Analyzers were met to acquire and confirm basic data and survey possibilities of the Biochemistry Analyzers market.

Get upto 25% off on this report:https://marketresearch.biz/report/biochemistry-analyzers-market/#inquiry

The research provides explanations to the accompanying key queries of Biochemistry Analyzers industry:

1. What will be the market size and improvement pace of the Biochemistry Analyzers market for the assessed time period 2020 2029 transversely over different regions?

2. What are the key primary purposes expected to shape the destiny of the Biochemistry Analyzers business around the globe?

3. What procedures are the unquestionable traders changing in accordance with stay before their Biochemistry Analyzers contenders?

4. Which critical examples are influencing the improvement of the Biochemistry Analyzers market worldwide?

5. Which factors can avoid, challenge or even cutoff the improvement of the Biochemistry Analyzers market the world over?

6. What are the odds or future conceivable outcomes for the business visionaries working in the industry for the measure time allotment, 2020 2029?

Table of Contents:

1. Biochemistry Analyzers Market Survey.

2. Executive Synopsis.

3. Global Biochemistry Analyzers Market Race by Manufacturers.

4. Global Biochemistry Analyzers Production Market Share by Regions.

5. Global Biochemistry Analyzers Consumption by Regions.

6. Global Biochemistry Analyzers Production, Revenue, Price Trend by Type.

7. Global Biochemistry Analyzers Market Analysis by Applications.

8. Biochemistry Analyzers Manufacturing Cost Examination.

9. Advertising Channel, Suppliers, and Clienteles.

10. Market Dynamics

11. Global Biochemistry Analyzers, Market Estimate.

12. Investigations and Conclusion.

13. Important Findings in the Global Biochemistry Analyzers Study.

14. Appendixes.

15. company Profile.

About Us:

MarketResearch.biz is a global market research and consulting service provider specialized in offering a wide range of business solutions to their clients including market research reports, primary and secondary research, demand forecasting services, focus group analysis and other services. We understand that how data is important in todays competitive environment and thus, we have collaborated with industrys leading research providers who work continuously to meet the ever-growing demand for market research reports throughout the year.

Contact Us:

Mr. Benni Johnson

MarketResearch.Biz (Powered By Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York City, NY 10170,

United States

Tel:+1 347 826 1876

Website:https://marketresearch.biz/

Read the original here:
Biochemistry Analyzers Market: 2020 With Top Competitors Analysis And Insights - TheLoop21

The research report on the global Biochemistry Analyzers marketprovides a comprehensive outlook of the equipment and technological devices employed in the manufacturing of the Biochemistry Analyzers market products. From industry chain analysis to cost structure analysis, the report examines various factors of the industry, including production and end-use segments of the Biochemistry Analyzers market. The current trends in the pharmaceutical industry have been highlighted in the report to evaluate their influence on the overall output of the Biochemistry Analyzers market. The Biochemistry Analyzers Market analyzed in this study is speculated to grow at a CAGR of XX% during the forecast period (2019-2026).

Fill in your details to get your hands on an Exclusive Sample of this Report @ https://www.marketexpertz.com/sample-enquiry-form/71860

Competitive Landscape:

The Biochemistry Analyzers market is moderately competitive and includes numerous key players. When looking at market share, few industry players predominantly constitute the worldwide market. With the growing awareness among patients and high prevalence of diseases like cancer, new companies are also expected to find their way into the market in the near future.

Some of the major players engaged in the market are :

Roche Diagnostics GmbH, Siemens AG, Beckman Coulter Inc., Abbott Diagnostics Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Hologic, Inc., Randox Laboratories Ltd., Awareness Technology, Inc., Transasia Biomedicals Ltd, Nova Biomedical Corp.

Results of the latest scientific undertakings for the development of new Biochemistry Analyzers products have also been considered. Factors that can potentially influence the leading industry players to implement synthetic sourcing of market products have also been studied in this investigative report. The inferences drawn in this study are valuable for any company operating in the industry. Every organization contributing to the global production of the Biochemistry Analyzers market products has been profiled in this report, in order to study the insights on cost-effective manufacturing methods, competitive landscape, and new avenues for applications.

Biochemistry Analyzers Market Segmentation:

Type of Biochemistry Analyzers Market:

Semi-automated Biochemistry Analyzer, Fully Automated Biochemistry Analyzer

Application of Biochemistry Analyzers Market:

Clinical Diagnostics, Bioreactor Byproduct Detection, Drug Development Applications, Others

Grab Your Report at an Impressive Discount! Please Click Here @ https://www.marketexpertz.com/discount-enquiry-form/71860

The varying scenarios across the global market have been examined in this study, providing an overview of how the Biochemistry Analyzers products have established their place in this rapidly-evolving sector. Industry participants will be able to formulate their strategies and tactics by assessing the speculated market size for the forecast mentioned in the report. Favorable regional markets for the Biochemistry Analyzers have been described, which are expected to impact the global expansion strategies of the leading organizations. Additionally, key manufacturers have been profiled comprehensively in this research report.

In market segmentation by geographical regions, the report has analyzed the following regions-

North America

Europe

China

Japan

Middle East & Africa

India

South America

Others

With the existing market standards evaluated, this research report also explains the latest strategic initiatives and patterns of the market players in an unbiased way. The report can be construed as a presumptive business record that can aid the readers functioning in the global market devise their plans effectively, to reach the desired position in the market in the forecast period.

Read the Comprehensive Report with a meticulous TOC and panoramic coverage of the [emailprotected] https://www.marketexpertz.com/industry-overview/biochemistry-analyzers-market

Report Methodology:

The data contained in this report has been derived through both primary and secondary research methodologies.

Primary research methodology includes interaction with service providers, suppliers, and industry professionals. Secondary research methodology entails a thorough examination of relevant literature like company annual reports, financial reports, and exclusive databases.

This report provides:

Request customized copy of Biochemistry Analyzers report

We are grateful to you for reading our report. If you wish to find more details of the report or want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

Need to customized? Ask Our Expert @ https://www.marketexpertz.com/customization-form/71860

Continued here:
Biochemistry Analyzers Market: A Latest Research Report to Share Biochemistry Analyzers Industry Insights and Dynamics By 2026 - Market Strategies

December 09, 2019

A scientist whose research has transformed our understanding of Australias iconic mammals has been recognised by the Australian Academy of Science. Professor Marilyn Renfree AO FAA has been awarded the Academys highest honour in the biological sciencesthe Macfarlane Burnet Medal and Lecture.

For half a century the committed reproductive and developmental biologist and conservationist from the University of Melbourne has been using the tammar wallaby, a small macropodid marsupial native to South and Western Australia, to study their reproduction and development.

Professor Renfree has developed contraceptive strategies for kangaroos and koalas and established marsupials as unique biomedical models for understanding human reproduction.

She is now a world authority on marsupial reproduction and development and has pioneered research on some of Australias most iconic creatures including kangaroos, koalas and now echidnas.

And with passion for her work as strong as ever, she has no plans of slowing down. Professor Renfree has just embarked on the worlds first study of the development of the embryo and newly hatched pouch young from the echidna.

Professor Renfree said hardly anything was known about marsupials when she started out.

Im passionately Australian and I really wanted to work on something Australian but when I started honours I said to my prospective supervisors: I wanted to do biochemistry and fieldwork. And they laughed at me. Well, Im still really doing biochemistry and fieldwork.

Her first paper published from her PhD in 1972 was aNaturepublication.

In her distinguished career Professor Renfree has made numerous research breakthroughs. In research with colleagues Professor Renfree conducted the first genome sequencing of an Australian marsupial, the tammar wallaby, providing new information on their evolution.

She also showed that certain genes directly control sexual development during pregnancy and even after birth in marsupials, providing a new understanding of the relative influence of genes versus hormones in sexual differentiation in all mammals. With colleagues she also discovered a new hormone pathway that explains some human disorders of sexual development.

Professor Renfree said Australia is sitting on a biological goldmine because it is home to a unique assembly of mammalsthe marsupials and monotremes.

The impact of Australias recent bushfires on Australian mammals has highlighted Australia and the worlds fascination with these special animals. We really need to put more effort, time and money into conserving and doing research on them, Professor Renfree said.

Australia has the distinction of having the worst record of mammal extinctions of any developed country and thats not a record you want to be proud of.

Professor Renfree said the Academy award is a huge honour.

Im receiving it on behalf of all of my students, PhD students and postdocs and collaborators. Without them I could have only done a fraction of what I've done, Professor Renfree said.

She was nominated for the medal by Professor James Angus FAA from the University of Melbourne.

Professor Renfree is a pioneer and forward thinker who has an ability to excite and inspire scientists from around the world by providing new insights through the study of the unique evolutionary innovations in the reproductive systems of marsupials and monotremes, Professor Angus said.

The basic science and the clinical impact of her work for humans are as important as the direct benefits of her work for Australias marsupials. Her research has undoubtedly opened the eyes of the academic world and beyond to the value of these iconic Australian mammals both for their intrinsic interest and as unique biomedical models.

Professor Renfree will receive the medal and give a lecture at the Academys Science at the Shine Dome event in May 2020. The Macfarlane Burnet Medal and Lecture honours the contributions to science by Sir MacFarlane BurnetOMKBMDFAAFRSNobel Laureate.

See the original post here:
Researcher who uncovered the sex life of marsupials awarded Academy's most prestigious medal - Australian Academy of Science

GlobalBiochemistry Analyzers Market: Overview

The report details an exhaustive account of the global biochemistry analyzers market along with numerous associated factors. Some of these factors that are included in the report are drivers, restraints, competitive analysis, latest trends and opportunities, geographical outlook, and many other aspects. The study covered in the report spans a forecast period from 2018 to 2028. From an overall perspective, the report is expected to exist as a valuable insight to businesses which are already operating in the global biochemistry analyzers market, as well for those who intend to newly establish themselves in this environment.

GlobalBiochemistry Analyzers Market: Market Potential and Restraints

Widespread advancements in the medical field have primarily been responsible for driving the global biochemistry analyzers market. Moreover, with rising geriatric population, the numbers of health issues are gradually increasing, thereby increasing demand for relevant treatments that involve biochemical analyzers. In addition, these analyzers possess a high rate of identification of a specific pathogen, consequently providing high clarity and accuracy.

Request Brochure of Biochemistry Analyzers Market Report

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=50526

These characteristics make the use of the biochemical analyzers more suitable than other alternatives, thereby boosting growth in the global biochemical analyzers market. Technological advancements are expected to increase even more in the near future, consequently projected to further stoke expansion in the global biochemical analyzer market. Increasing use of the analyzers in drug monitoring, drug abuse detection, and drug provision, owing to rise in the number of health conditions too is notably contributing towards growth witnessed by the global biochemistry analyzers market.

However, this market is hindered owing to several factors. A prominent obstacle present in its growth involves lack of expertise and shortage of necessary manpower required to provide the treatments that involves use of biochemistry analyzers in remote and underdeveloped regions. Owing to this, the market remains restrained geographically. Moreover, high costs of manufacturing the analyzer compounds might cause difficulties for small-scale healthcare centers to afford the required equipment.

In addition, there are several complexities involved with carrying out medical processes that make use of the analyzers. Due to this, people might prefer traditional and cheaper alternatives, which is notably hampering progress in the global biochemistry analyzers market. Nonetheless, key players are soon expected to introduce cost-effective analyzer production procedures, thus blanketing most restraints affecting the global biochemistry analyzers market.

Request for a Discount on Biochemistry Analyzers Market Report

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=50526

GlobalBiochemistry Analyzers Market: Geographical Outlook

This market is mainly spread across North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. Of these, a strong medical infrastructure in North America has made this region hold a leading stance with maximum market share. Many organizations are growing in the global biochemistry analyzers market in North America owing to the availability of necessary funds, mainly to conduct research and develop new and efficient treatments. However, apart from North America, Asia Pacific too showcases a splendid growth present in the global biochemistry analyzers market. This is majorly due to the introduction and utilization of various treatment procedures wherein biochemistry analyzers play a huge role. In addition, several companies are pouring extensive investments in developed economies located in Asia Pacific, which is anticipated to strengthen the market in this region.

GlobalBiochemistry Analyzers Market: Competitive Landscape

This market depicts the presence of a substantially competitive vendor landscape, with the presence of a handful of players exerting their respective dominance. Regulation of treatment costs, achieving geographical expansion, and bringing forth medical treatment efficiency are key strategies implemented by most players operating in the global biochemistry analyzers market. Abbott Diagnostics Inc., Hologic, Inc., Transasia Biomedicals Ltd., Beckman Coulter Inc., Roche Diagnostics GmbH, Siemens AG, Randox Laboratories Ltd., Awareness Technology, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and Nova Biomedical Corp., are chief players operating in this sector.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

ContactTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY 12207United StatesTel:+1-518-618-1030USA Canada Toll Free:866-552-3453Email:[emailprotected]Website:http://www.transparencymarketresearch.com

Read the original:
Biochemistry Analyzers Market to Receive Overwhelming Hike in Revenues by 2026 - Montana Ledger

The importance of proteostasis is becoming increasingly apparent as disrupted proteostasis and dysregulation of proteostasis-associated networks has been linked with aging and many age-associated diseases such as Alzheimers, Parkinsons and Huntingtons disorders. In recognition of the importance of this subject, PLOS ONE, alongside PLOS Biology, launched a Call for Papers on the topic of Autophagy and Proteostasis earlier this year. We welcomed a range of submissions that provided insight into the molecular and cellular machinery, and mechanisms that regulate autophagy and the crosstalk of this process with other protein quality control pathways to ensure proteostasis. These studies also underline the importance of all these cellular pathways in pathophysiological conditions and aging. The Guest Editors are Sharon Tooze (Francis Crick Institute, United Kingdom), Fulvio Reggiori (University Medical Centre Groningen, The Netherlands) and Thorsten Hoppe (Institute for Genetics and CECAD Center for Aging Research, University of Cologne, Germany).

We are happy to launch this Collection today, which includes five studies published in PLOS ONE that highlight the relevance of autophagy and other pathways such as the ubiquitin proteasome-system in maintaining protein homeostasis. In human cells, Ferreira et al. showed that when the STUB1/CHIP ubiquitin ligase is inactivated, cells increase secretion of extracellular vesicles (EVs) enriched in ubiquitylated or stabilized proteins, suggesting that cells use these EVs to dispose of proteotoxic material. Studying another E3 ubiquitin ligase, Si and colleagues investigate the mechanism for Pink1- and Parkin-mediated mitophagy in indirect flight muscles in Drosophila melanogaster, and showed that Pink1/Parkin are crucial for muscle function in aged muscles in an Atg1-dependent manner. Autophagy also plays crucial roles in the fungus Aspergillus niger and Kaur and Punekar revealed that acidogenic growth appears to mimic a nutrient deficient condition, and acidogenic growth and metabolism are compromised in atg1 and atg8 strains of A. niger.

In addition, two papers in the Collection showcase research investigating proteostasis dysfunction in disease states, and potential ways to modulate autophagy for therapeutic uses. Aviazidis et al. study proteostasis network dysfunction caused by unbalanced karyotypes using human Downs syndrome fibroblasts, showing that decreased abundance of SNARE family members STX17 and VAMP8 maybe responsible for reducing autophagic flux by impairing autophagosome-lysosome fusion. Bhaskar et al. identify lipoarabinomannan (LAM), a crucial lipid component of the Mycobacterium indicius pranii cell-wall, as an inducer of autophagy that leads to the enhancement of co-localization between Mycobacteriaum tuberculosis and phago-lysosomes, and increased clearance of this bacterium in macrophages.

Papers will continue to be added to the Collection as they are published. Stay tuned for new articles and additional insights on this important topic.

Fulvio Reggiori

Fulvio Reggiori is a Professor and Section Head of Molecular Cell Biology at the Department of Biomedical Sciences of Cells and Systems of the University Medical Centre Groningen, The Netherlands. Fulvio obtained in his PhD in Biochemistry from the University of Fribourg, Switzerland, in the laboratory of Professor Andreas Conzelmann. Subsequently, he moved to the MRC Laboratory in Molecular Biology in Cambridge to join the laboratory of Dr. Hugh Pelham, UK in 1998. In 2001, Fulvio moved to the University of Michigan in Ann Arbor, USA to the laboratory of Professor Daniel Klionsky, where he started working on different aspects of the molecular mechanisms of autophagy in yeast. In 2005 he was appointed as an Assistant Professor at the Department of Cell Biology of the University Medical Center Utrecht, The Netherlands before becoming an Associate Professor in 2011. Fulvio moved his lab in 2015, to the Department of Department of Biomedical Sciences of Cells and Systems of the University Medical Center Groningen where he became Professor. His research continues to investigate the molecular mechanisms of autophagy using Saccharomyces cerevisiae as a model organism as well as understanding the interaction between autophagy and pathogens, in particular viruses.

Sharon Tooze

Sharon Tooze is a Senior Group Leader at the Francis Crick Institute, London, UK. She has a long-standing interest in understanding organelle biogenesis using molecular cell biology approaches. Sharon received her PhD and undertook a postdoctoral research position in Wieland Huttners lab at the European Molecular Biology Laboratory (EMBL). She established a lab at Imperial Cancer Research Fund, UK which later became known as the Cancer Research UK London Research Institute. In 2015 she moved her lab to the Francis Crick Institute where her research continues to focus on autophagy. Her current interests are focused on expanding our knowledge of the core autophagy proteins in mammalian cells at the molecular level, in particular the autophagy proteins which initiate the formation of the autophagosome.

Thorsten Hoppe

Thorsten Hoppe is a Professor at the Institute for Genetics and the Center for Aging Research (CECAD) at the University of Cologne, Germany. He received his PhD from the University of Heidelberg working in the lab of Stefan Jentsch at the Center for Molecular Biology in Heidelberg (ZMBH) and the Max Planck Institute of Biochemistry in Martinsried. He undertook is postdoctoral work in the Department of Molecular Neurogenetics in the group of Ralf Baumeister at the LM-University of Munich before setting up his own group in 2003 at the Centre for Molecular Neurobiologie at the University of Hamburg (ZMNH). In 2008 he moved his lab to the Institute for Genetics and was Acting Director from 2011 to 2013. His research focuses on understanding the role proteostasis plays in aging and age-associated diseases.

Go here to see the original:
Introducing the Autophagy and Proteostasis Collection - PLoS Blogs

Chieko Hara, University Relations

From left, Dan Sui, vice chancellor for research and innovation; Roger Koeppe, Distinguished Professor of chemistry and biochemistry; and Robert "Bobby" McGehee, executive director of Arkansas Biosciences Institute and dean at UAMS Graduate School

Science and engineering researchers at the University of Arkansas use research awards from the Arkansas Biosciences Institute to improve the health of Arkansans and prevent smoking-related illnesses.

Seed funding from the institute, a statewide consortium consisting of five research institutions, often enables researchers to produce preliminary results that help them and the university compete for large grants from federal agencies, such as the National Science Foundation and the National Institutes of Health.

As the U of A's institutional director and ABI representative for 11 years, Roger Koeppe, Distinguished Professor in the Department of Chemistry and Biochemistry, helped many colleagues secure funding from the institute. Koeppe was recognized for his service Thursday during a faculty town hall meeting to discuss future funding priorities and strategies of the Arkansas Biosciences Institute. The meeting was hosted by Dan Sui, vice chancellor for research and innovation.

"ABI funds have made a huge difference on this campus, certainly in terms of biosciences research, but also as leverage to attract and recruit top investigators," Sui said. "Obviously, Roger has been responsible so much its success on this campus, and we want to recognize his enormous contribution."

Earlier this semester, Chancellor Joe Steinmetz appointed Sui to serve as the new ABI institutional director.

The Arkansas Biosciences Institute was established as a result of Arkansas' share of the 1998 nationwide tobacco settlement. Health care leaders in the state sought a productive way to disperse the state's share of the settlement. TheArkansas Biosciences Institutewas created as a conduit for research that could help reduce or prevent smoking-related illnesses.

Arkansas voters endorsed the proposed Tobacco Settlement Proceeds Act of 2000, and the Arkansas Legislature enacted the provisions of that proposal as Acts 1569 through 1580 of 2001. Part of that legislation established the institute as a consortium of five research institutions: the University of Arkansas, the University of Arkansas System Division of Agriculture, the University of Arkansas for Medical Sciences, Arkansas State University and Arkansas Children's Hospital. Since ABI's beginning, scientists at these institutions have focused on biomedical and agricultural research with medical implications.

Robert "Bobby" McGehee, executive director of the Arkansas Biosciences Instituteand dean at University of Arkansas for Medical Sciences Graduate School, also recognized Koeppe during Thursday's meeting. He and Koeppe served together for more than a decade.

McGehee said Arkansas is one of only two states that uses all of its tobacco settlement money for heath inititatives and healthcare research. Sui said the university will continue to use ABI funds to make new strategetic investments in biosciences research.

Link:
Koeppe Recognized for Service as ABI Institutional Director at University of Arkansas - University of Arkansas Newswire

Gabriela K. Popescu, professor of biochemistry in the Jacobs School of Medicine and Biomedical Sciences at UB, has been elected chair of the Council of Faculty and Academic Societies (CFAS) of the Association of American Medical Colleges (AAMC).

Popescu, a UB faculty member since 2006 and a UB alumna, began her two-year term as CFAS chair on Nov. 13 and will serve until Nov. 9, 2021, when she will become immediate past chair. As CFAS chair, she will serve as a member of the AAMCs board of directors until November 2021.

The AAMC represents the nations medical schools and teaching hospitals, and is dedicated to transforming health care through innovative medical education, cutting-edge patient care and groundbreaking medical research.

I am honored to step into this new role, Popescu says.

This year, she plans to engage and lead the CFAS Administrative Board in an overall evaluation of current activities, to identify areas of success and to find ways to more effectively serve as a voice for the faculty members the group represents.

CFAS formed in 2013 at the request of faculty who had formerly been active in the AAMCs Council of Academic Societies, with the goal of more directly engaging and representing faculty views and issues, and voicing them to the AAMC to help shape the development and implementation of its programs and policies.

As the largest of the AAMC councils, CFAS represents more than 173,000 full-time faculty with 350 faculty members, two representatives from each AAMC member school and society.

Popescu initially served on the administrative board, representing the Jacobs School. In 2017, she was named chair-elect and her primary responsibility was to chair the committee that organizes the annual CFAS spring meeting.

Last spring, she and CFAS colleagues organized what she calls a tremendously effective plenary session on sexual harassment in academic medicine and one of a few pioneering sessions held at national meetings on the subject. The session included opportunities for participants to learn and practice new skills designed to disrupt unconscious bias and to foster a more inclusive climate for women.

As CFAS chair for the next two years, she says, it will be important to continue to chisel the identity of this relatively new council, to engage and empower faculty representatives to speak loudly and effectively to the most critical issues facing academic medicine, and to foster a culture of inclusivity and appreciation.

Popescu believes that her experiences as a bench scientist, as a woman in academic medicine and as an immigrant serve her well in this leadership position.

Specifically, I feel that at this particular juncture, when the gender composition of our student body for the first time in history matches that of our nations population, it is important to commit ourselves to advancing and achieving equity along the entire career span of scientists and physicians, and across the spectrum of disciplines and specialties, she says.

Popescu points out that as a bench scientist, she is a representative of what is arguably the smallest of the three traditional tracks in academic medicine, the others being educators and clinicians.

Scientists here in the Jacobs School, like many others in academic medicine, have felt the specter of reduced National Institutes of Health funding and budgetary cuts for research amid talk of the high cost that basic research imposes on medical schools, she says.

My CFAS colleagues have mobilized under this threat and have been instrumental in demonstrating the value that science brings to the mission of medical schools, she continues. With this evidence from the trenches, the AAMC partnered with many others to make a successful case for the profitable investment that scientific discoveries represent for medicine. Today, bipartisan legislatures support predictable and sustainable funding for the NIH, and many scientists at the Jacobs School and across the country receive federal funds to push the boundaries of knowledge.

Popescu currently directs research funded by three NIH awards totaling more than $3.5 million. She has invested much of her career studying afamily of brain receptors called NMDA (N-methyl-D-aspartate) receptors that are critical to learning and memory. Her research on these receptors may lead to more effective strategies to treat a range of neurological and neurodegenerative conditions, from stroke, chronic pain and addiction to disorders such as schizophrenia and epilepsy.

Go here to read the rest:
Popescu works to empower faculty, foster inclusivity as chair of national group - UB Now: News and views for UB faculty and staff - University at...

Scientists researching a key aspect of biochemistry in living creatures have been taking a very close look at the tiny Caenorhabditis elegans roundworm. Their latest results show that when these nematodes get put under more biochemical stress early in their lives, they somehow tend to live longer.

This type of stress, called oxidative stress - an imbalance of oxygen-containing molecules that can result in cellular and tissue damage - seems to better prepare the worms for the strains of later life, along the same lines as the old adage that whatever doesn't kill you, makes you stronger.

You might think that worm lifespans have no bearing on human life. And surely, until we have loads more research done in this field, it would be a big leap to say the same principles of prolonging one's lifespan might hold true for human beings.

But there's good reason to put C. elegans through the paces. This model organism has proven immensely helpful for researchers trying to better understand key biological functions present in worm and human alike - and oxidative stress is one such function.

The little wriggly creatures are known to have significant variations in their lifespan even when the whole population is genetically identical and grows up in the exact same conditions. So the team went looking for other factors that affect C. elegans' longevity.

"The general idea that early life events have such profound, positive effects later in life is truly fascinating," says biochemist Ursula Jakob from the University of Michigan.

Jakob and her colleagues sorted thousands of C. elegans larvae based on the oxidative stress levels they experienced during development this stress arises when cells produce more oxidants and free radicals than they can handle. It's a normal part of the ageing process, but it's also triggered by exercise and a limited food supply.

One way to measure this stress is by the levels of reactive oxygen species (ROS) molecules an organism produces - simply put, this measurement indicates the biochemical stress an organism is under. In the case of these roundworms, the more ROS were produced during development, the longer their lifespans turned out to be.

(University of Michigan)

To explain how this effect of ROS might come about, the researchers went looking for changes in the worms' genetic regulation, specifically those genes that are known to be involved in dealing with oxidative stress.

While doing so, they detected a key difference - the nematodes exposed to more ROS during development appeared to have undergone an epigenetic change (a gene expression switch that can happen due to environmental influences) thatincreased the oxidative stress resistance of their body's cells.

There are still a lot of questions to answer, but the researchers think their results identify one of the stochastic or random influences on the lifespan of organisms; it's something that has been hypothesised in the field of the genetics of ageing. And down the line, it may turn out to be relevant for ageing humans, too.

"This study provides a foundation for future work in mammals, in which very early and transient metabolic events in life seem to have equally profound impacts on lifespan," the researchers conclude.

The study has been published in Nature.

Continue reading here:
Fascinating Study Finds That Stressed Out Baby Worms Tend to Live Longer - ScienceAlert

Global Bench-top Veterinary Biochemistry Analyzers Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025  Industry News Info

Read the original here:
Global Bench-top Veterinary Biochemistry Analyzers Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025 - Industry News Info